You are here: Industry Insights > FDA

News List

FDA recalls liquid pharma products after bacterial contamination detected pharmafile
August 18, 2017
The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products due a possible bacterial contamination which could pose a threat to vulnerable patients through threat of serious infection.
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia worldpharmanews
August 18, 2017
The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
FDA Approves Besponsa for Relapsed or Refractory ALL americanpharmaceuticalreview
August 18, 2017
The U.S. Food and Drug Administration approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
FDA Accepts Medivir´s IND Application for MIV-711 americanpharmaceuticalreview
August 17, 2017
Medivir announces the Investigational New Drug (IND) application for MIV-711 has been accepted and the IND is now open with the FDA (U.S. Food and Drug Administration).
Accelerated drugs approval evaluated europeanpharmaceuticalreview
August 17, 2017
Researchers have evaluate the features of pre-approval and post-approval clinical trials of drugs granted Accelerated Approval by the FDA…
FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements americanpharmaceuticalreview
August 15, 2017
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due
Drug approval harmonisation shows savings potential europeanpharmaceuticalreview
August 15, 2017
Researchers have compared the regulatory authorities responsible for approving drugs and medical products to verify their effectiveness and safety…
Natco gets US FDA nod to market renal disease drug expressbpd
August 15, 2017
The product, as the first generic, will be launched shortly in the US market
Zydus settles patent case over Aptalis’ drug Canasa expressbpd
August 15, 2017
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Achieve Announces FDA Acceptance of IND Application for Cytisine americanpharmaceuticalreview
August 14, 2017
Achieve Life Sciences announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for cytisine, an established smoking cessation treatment that has been approved and marketed in Central and Eastern Eur

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page